GlassScriptPhysician profile
Shahid Parvez
NPI 1265434922
$2,427.48
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $204 · 2021: $279 · 2022: $252 · 2023: $326 · 2024: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $403.31 | 2020-2024 | Fintepla |
| Greenwich Biosciences, INC. | $341.94 | 2019-2021 | |
| Aquestive Therapeutics, INC. | $275.70 | 2019-2020 | |
| Eisai INC. | $196.17 | 2019-2021 | |
| Neurelis, INC. | $185.86 | 2023-2024 | Valtoco |
| Sunovion Pharmaceuticals INC. | $178.73 | 2019-2020 | |
| Medtronic USA, INC. | $150.62 | 2019-2020 | |
| Tris Pharma INC | $132.15 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $119.52 | 2022-2024 | |
| Shire North American Group INC | $74.47 | 2019 | |
| Ironshore Pharmaceuticals INC. | $68.65 | 2019-2021 | |
| Sk Life Science, INC. | $55.65 | 2021-2022 | |
| Harmony Biosciences LLC | $35.57 | 2020 | |
| Mallinckrodt Enterprises LLC | $34.49 | 2019 | |
| Travere Therapeutics, INC. | $31.63 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $27.52 | 2019 | |
| Biomarin Pharmaceutical INC. | $26.79 | 2023 | Brineura |
| Supernus Pharmaceuticals, INC. | $17.41 | 2019 | |
| Sarepta Therapeutics, INC. | $17.29 | 2019 | |
| Sumitomo Pharma America, INC. | $16.20 | 2023 | Aptiom |
| Vertical Pharmaceuticals, LLC | $13.72 | 2019 | |
| Livanova USA, INC. | $12.33 | 2020 | |
| Adlon Therapeutics L.P. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahid Parvez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.